Zachary Roberts
EVP of R&D · 2 filings · Latest: Feb 2, 2026
Allogene Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALLO | Zachary Roberts | EVP of R&D | Feb 2, 2026 | Sale | $1.77 | 35,700 | $63.2K | 581,166 | |
ALLO | ZACHARY J ROBERTS | — | Feb 2, 2026 | Proposed Sale | $1.77 | 35,700 | $63.4K | — | |
ALLO | Zachary Roberts | EVP of R&D | Jan 21, 2026 | Sale | $1.56 | 26,269 | $41.0K | 616,866 | |
ALLO | Roberts Zachary | — | Jan 21, 2026 | Proposed Sale | $1.56 | 26,269 | $40.9K | — | |
ALLO | Roberts Zachary | — | Feb 3, 2025 | Proposed Sale | $1.70 | 18,832 | $32.0K | — | |
ALLO | Roberts Zachary | — | Jan 21, 2025 | Proposed Sale | $1.78 | 27,199 | $48.5K | — |